BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 9276606)

  • 1. Rational clinical immunotherapy for multiple sclerosis.
    Hunter SF; Weinshenker BG; Carter JL; Noseworthy JH
    Mayo Clin Proc; 1997 Aug; 72(8):765-80. PubMed ID: 9276606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunotherapy in multiple sclerosis, Part 1.
    Becker CC; Gidal BE; Fleming JO
    Am J Health Syst Pharm; 1995 Sep; 52(18):1985-2000. PubMed ID: 8528866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunomodulatory therapy in multiple sclerosis].
    Csépány T; Bereczki D
    Ideggyogy Sz; 2004 Nov; 57(11-12):401-16. PubMed ID: 15662768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AANA Journal course: update for nurse anesthetists--an overview of multiple sclerosis and implications for anesthesia.
    Schneider KM
    AANA J; 2005 Jun; 73(3):217-24. PubMed ID: 16010775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunotherapy of multiple sclerosis--current practice and future directions.
    Tullman MJ; Lublin FD; Miller AE
    J Rehabil Res Dev; 2002; 39(2):273-85. PubMed ID: 12051470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunotherapy in multiple sclerosis, Part 2.
    Becker CC; Gidal BE; Fleming JO
    Am J Health Syst Pharm; 1995 Oct; 52(19):2105-20; quiz 2132-4. PubMed ID: 8535945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pediatric multiple sclerosis.
    Bigi S; Banwell B
    J Child Neurol; 2012 Nov; 27(11):1378-83. PubMed ID: 22914372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current disease-modifying treatment of multiple sclerosis.
    Derwenskus J
    Mt Sinai J Med; 2011; 78(2):161-75. PubMed ID: 21425262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunotherapy of multiple sclerosis.
    Weiner HL; Hafler DA
    Ann Neurol; 1988 Mar; 23(3):211-22. PubMed ID: 3288084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recommendations for diagnosis and management of multiple sclerosis.
    Kes VB; Zavoreo I; Serić V; Solter VV; Cesarik M; Hajnsek S; Pasić MB; Gabelić T; Silvio B; Butković SS; Lusić I; Grbelja LD; Vladić A; Bielen I; Antoncić I; Demarin V; ; ;
    Acta Clin Croat; 2012 Mar; 51(1):117-35. PubMed ID: 22920014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic decision making in a new drug era in multiple sclerosis.
    Keegan BM
    Semin Neurol; 2013 Feb; 33(1):5-12. PubMed ID: 23709208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disease-modifying drugs for the early treatment of multiple sclerosis.
    Flachenecker P
    Expert Rev Neurother; 2004 May; 4(3):455-63. PubMed ID: 15853542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pixantrone (BBR2778): a new immunosuppressant in multiple sclerosis with a low cardiotoxicity.
    Gonsette RE; Dubois B
    J Neurol Sci; 2004 Aug; 223(1):81-6. PubMed ID: 15261566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunotherapy of multiple sclerosis: the use of magnetic resonance imaging in the evaluation of clinical trials].
    Ozawa K; Saida T
    Rinsho Shinkeigaku; 1995 Dec; 35(12):1501-3. PubMed ID: 8752444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corticosteroids treatment.
    Pozzilli C; Marinelli F; Romano S; Bagnato F
    J Neurol Sci; 2004 Aug; 223(1):47-51. PubMed ID: 15261560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The argument against the use of cyclophosphamide and mitoxantrone in the treatment of multiple sclerosis.
    Jeffery DR
    J Neurol Sci; 2004 Aug; 223(1):41-6. PubMed ID: 15261559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current therapeutic recommendations in multiple sclerosis.
    Berger T
    J Neurol Sci; 2009 Dec; 287 Suppl 1():S37-45. PubMed ID: 20106347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasmapheresis, lymphocytapheresis, and immunosuppressive drug therapy in multiple sclerosis.
    Hauser SL; Fosburg M; Kevy S; Weiner HL
    Prog Clin Biol Res; 1982; 106():239-54. PubMed ID: 6184727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of multiple sclerosis--1. New drugs may be effective but there still are frequent relapses].
    Svenningsson A; Andersson M; Olsson T
    Lakartidningen; 1998 Dec; 95(49):5623-7, 5630. PubMed ID: 9863300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunopathogenesis and immunotherapy of multiple sclerosis.
    Hemmer B; Nessler S; Zhou D; Kieseier B; Hartung HP
    Nat Clin Pract Neurol; 2006 Apr; 2(4):201-11. PubMed ID: 16932551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.